Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma

Hepatology

Volumn 59, Issue 3, 2014, Pages 1207-1207

  Waidmann, Oliver ^a   Kronenberger, Bernd ^a   Scheiermann, Patrick ^a,b   Köberle, Verena ^a   Mühl, Heiko ^a   Piiper, Albrecht ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; TRANSCRIPTION FACTOR;

ACUTE PHASE RESPONSE; ALCOHOL LIVER CIRRHOSIS; CANCER PROGNOSIS; CARCINOGENESIS; DENDRITIC CELL; DISEASE SEVERITY; EPITHELIUM CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NATURAL KILLER CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TRANSDUCER;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INTERLEUKINS; LIVER NEOPLASMS; MALE; STAT3 TRANSCRIPTION FACTOR;

EID: 84896848288     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26528     Document Type: Letter

References (6)

1. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000;164:1814-1819.
2. Mühl H, Scheiermann P, Bachmann M, Härdle L, Heinrichs A, Pfeilschifter J. IL-22 in tissue protective therapy. Br J Pharmacol 2013; doi: 10.1111/bph.12196.
3. Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011;54:900-909.
4. Kronenberger B, Rudloff I, Bachmann M, Brunner F, Kapper L, Filmann N, et al. Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study. BMC Med 2012;10:102.
5. Boniface K, Guignouard E, Pedretti N, Garcia M, Delwail A, Bernard FX, et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 2007;150:407-415.
6. Wolk K, Witte E, Hoffmann U, Doecke WD, Endesfelder S, Asadullah K, et al. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol 2007;178:5973-5981.